Posted on 4/16/18
Idera Pharmaceuticals Enters into a Clinical Development Support Agreement with Pillar Partners Foundation
EXTON, Pa., April 16, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera”) (NASDAQ:IDRA), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel . . .
Posted on 4/11/18
Mylan Partners with Fujifilm Kyowa Kirin Biologics
Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced it is partnering with Fujifilm Kyowa Kirin Biologics Co., Ltd. to commercialize a biosimilar to Humira® (adalimumab) . . .
Posted on 4/11/18
Helius Medical Technologies Announces Uplisting to Nasdaq and Pricing of Public Offering of Class A Common Stock
NEWTOWN, Pa., April 11, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (TSX:HSM) (NASDAQ:HSDT) today announced the pricing of an underwritten public offering of 2,141,900 shares . . .
Posted on 4/8/18
Mylan Strengthens Its Capital Structure by Extending Its Debt Maturities with a Successful $1.5 Billion Bond Offering
Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced the pricing of a private offering of $1.5 billionaggregate principal amount of senior notes on March 28, . . .
Posted on 4/6/18
GNC Announces Plans to Expand into Australia
General Nutrition Corporation (NYSE: GNC) today announced plans to establish and develop a presence in the Australian market.Under a master franchise agreement, GNC will partner with . . .
Posted on 4/5/18
Windtree Therapeutics Announces Closing of $2.6 Million Private Placement
Windtree Therapeutics, Inc. (OTCQB: WINT),a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today announced that it has closed a $2.6 million . . .
Posted on 4/3/18
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
WAYNE, Pa., April 03, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led, biopharmaceutical company focused on identifying, developing and commercializing innovative and differentiated therapies . . .
Posted on 4/3/18
Idera Pharmaceuticals Files Definitive Proxy Statement in Connection with Pending Merger with BioCryst Pharmaceuticals
EXTON, Pa., April 02, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) (“Idera”), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel . . .
Posted on 4/2/18
Better Buy: Celgene Corporation vs. Gilead Sciences
Biotech stocks have been outstanding growth vehicles for investors over the better part of the last decade. Top dogs like Celgene Corp. (NASDAQ:CELG) and Gilead Sciences(NASDAQ:GILD), . . .
Posted on 3/27/18
Alamo Pharma Services Partners with Thingee Corp.
DOYLESTOWN, Pa., March 27, 2018 (GLOBE NEWSWIRE) -- Alamo Pharma Services (“Alamo”) and Thingee Corporation (“Thingee”) have announced a strategic partnership utilizing Thingee’s iDetail platform that . . .
Posted on 3/20/18
Forbes Magazine Names CSL Limited Among Top 50 Employers in the World
Forbes has named global biotechnology leader CSL Limited among the world's Top 50 employers, landing at no. 42 in the business media's annual Global 2000 survey.The . . .
Posted on 3/27/18
Interview with Chris Cashman, Chairman and CEO of Marinus Pharmaceuticals - Part III
Brought to you by Newmark Knight Frank
Posted on 3/21/18
Interview with Chris Cashman, Chairman and CEO of Marinus Pharmaceuticals - Part II
Brought to you by Newmark Knight Frank
Posted on 3/16/18
Interview with Chris Cashman, Chairman and CEO of Marinus Pharmaceuticals - Part I
Brought to you by Newmark Knight Frank
Posted on 3/12/18
Windtree and Eleison Announce Collaboration
Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, and Eleison Pharmaceuticals, Inc., a specialty pharmaceutical company . . .
Posted on 3/6/18
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
WAYNE, Pa., March 06, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led, biopharmaceutical company focused on identifying, developing and commercializing innovative and differentiated therapies . . .
Posted on 3/5/18
Onconova Therapeutics Announces License Agreement with Pint Pharma
NEWTOWN, Pa., March 05, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat . . .
Posted on 3/5/18
Celgene: Parsing The Ozanimod Debacle
Source: European Pharmaceutical ReviewCelgene (CELG) gave the market some bad news earlier this week. The company announced it received a Refusal To File ("RTF") letter from . . .
Posted on 3/2/18
Trevena Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CHESTERBROOK, Pa., March 02, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced that the independent Compensation Committee of the Board of Directors of the Company . . .
Posted on 3/1/18
Genesis HealthCare Regains Compliance With NYSE Continued Listing Standard
KENNETT SQUARE, Pa., March 01, 2018 (GLOBE NEWSWIRE) -- Genesis HealthCare (NYSE:GEN), one of the nation’s largest providers of post-acute care, today announced that it received . . .
Posted on 2/28/18
Alamo Pharma Services Recognized by Training Magazine asa 2018 Training Top 125 Winner
DOYLESTOWN, Pa., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Alamo Pharma Services (“Alamo”) was recently recognized as one of Training magazine’s annual Training Top 125, that ranks . . .
Posted on 2/27/18
PhaseBio Awarded $2.8 Million NIH SBIR Grant
MALVERN, Pa., Feb. 27, 2018 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing therapies for the treatment of orphan diseases, today announced that . . .
Posted on 2/26/18
Centric Bank Announces Exclusive Practice Financing Partnership with the Pennsylvania Dental Association
Centric Financial Corporation, Inc., (CFCX), has entered into an exclusive endorsed practice financing partnership with the Pennsylvania Dental Association (PDA) and Pennsylvania Dental Association Insurance Services . . .
Posted on 2/22/18
Genesis Announces New Financing Commitments and Provides Updates to Previously Announced Restructuring Plans
KENNETT SQUARE, Pa., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Genesis HealthCare (NYSE:GEN) (Genesis or the Company), one of the nation’s largest providers of post-acute care, today . . .
Posted on 2/20/18
Celgene's Otezla-Colitis Story; Implications For Other Biotechs
IntroductionCelgene (CELG) is back to 2014 levels, closing Friday at $96.14. It first reached this price in August 2014. Yet I just want to sit with . . .
Pittsburgh
